Novel strategies for targeting the dimerization interface of HIV protease with cross‐linked interfacial peptides
- 12 January 2002
- journal article
- review article
- Published by Wiley in Peptide Science
- Vol. 66 (2) , 126-133
- https://doi.org/10.1002/bip.10232
Abstract
As the prevalence of AIDS continues to grow, and current therapeutic agents begin to lose efficacy, the need for alternative treatments to combat HIV has become significantly greater. Targeting the highly conserved dimerization interface of HIV protease (PR) with interfacial peptides has been shown to reduce the activity of the enzyme due to generation of inactive monomers. The potency of these peptide‐based inhibitors has been dramatically increased by cross‐linking the interfacial sequences derived from HIV PR. This review focuses on a variety of strategies to develop potent, low‐molecular‐weight dimerization inhibitors of HIV PR. © 2002 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 66: 126–133, 2002Keywords
This publication has 41 references indexed in Scilit:
- Approaches to the Design of Effective HIV-1 Protease InhibitorsCurrent Medicinal Chemistry, 2000
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug DesignAnnual Review of Biophysics, 1998
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Indinavir-associated lipodystrophyAIDS, 1998
- Molecular Recognition of Protein−Ligand Complexes: Applications to Drug DesignChemical Reviews, 1997
- HIV-1 Protease InhibitorsJAMA, 1997
- Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation.Proceedings of the National Academy of Sciences, 1995
- Active human immunodeficiency virus protease is required for viral infectivity.Proceedings of the National Academy of Sciences, 1988
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983